FR2544717B1 - Nicotinamide l-oxyde n-substitue, ses sels, procede pour leur preparation et compositions pharmaceutiques en contenant - Google Patents

Nicotinamide l-oxyde n-substitue, ses sels, procede pour leur preparation et compositions pharmaceutiques en contenant

Info

Publication number
FR2544717B1
FR2544717B1 FR8306681A FR8306681A FR2544717B1 FR 2544717 B1 FR2544717 B1 FR 2544717B1 FR 8306681 A FR8306681 A FR 8306681A FR 8306681 A FR8306681 A FR 8306681A FR 2544717 B1 FR2544717 B1 FR 2544717B1
Authority
FR
France
Prior art keywords
nicotinamide
salts
substituted
oxide
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8306681A
Other languages
English (en)
Other versions
FR2544717A1 (fr
Inventor
Dino Nisato
Sergio Boveri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR8306681A priority Critical patent/FR2544717B1/fr
Priority to IL69392A priority patent/IL69392A/xx
Priority to PH29372A priority patent/PH19511A/en
Priority to AU17807/83A priority patent/AU556247B2/en
Priority to EP83401638A priority patent/EP0101380A3/fr
Priority to CS835876A priority patent/CS241064B2/cs
Priority to GR72198A priority patent/GR78927B/el
Priority to HU832829A priority patent/HU191869B/hu
Priority to NO832894A priority patent/NO832894L/no
Priority to MA20093A priority patent/MA19871A1/fr
Priority to CA000434507A priority patent/CA1209995A/fr
Priority to OA58088A priority patent/OA07521A/fr
Priority to SU833634875A priority patent/SU1212323A3/ru
Priority to NZ205239A priority patent/NZ205239A/en
Priority to FI832919A priority patent/FI832919A/fi
Priority to PT77192A priority patent/PT77192B/fr
Priority to US06/522,749 priority patent/US4514408A/en
Priority to DD83253927A priority patent/DD213921A5/de
Priority to YU01690/83A priority patent/YU169083A/xx
Priority to DK367683A priority patent/DK367683A/da
Priority to PL1983243410A priority patent/PL141540B1/pl
Publication of FR2544717A1 publication Critical patent/FR2544717A1/fr
Application granted granted Critical
Publication of FR2544717B1 publication Critical patent/FR2544717B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8306681A 1982-08-13 1983-04-22 Nicotinamide l-oxyde n-substitue, ses sels, procede pour leur preparation et compositions pharmaceutiques en contenant Expired FR2544717B1 (fr)

Priority Applications (21)

Application Number Priority Date Filing Date Title
FR8306681A FR2544717B1 (fr) 1983-04-22 1983-04-22 Nicotinamide l-oxyde n-substitue, ses sels, procede pour leur preparation et compositions pharmaceutiques en contenant
IL69392A IL69392A (en) 1982-08-13 1983-08-01 N-oxide nicotinamide derivatives,their preparation and pharmaceutical compositions containing them
PH29372A PH19511A (en) 1982-08-13 1983-08-09 N-substituted nicotinamide 1-oxide,its salts,process for their preparation and pharmaceutical compositions containing them
AU17807/83A AU556247B2 (en) 1982-08-13 1983-08-09 N-substituted nicotinamide 1-oxide
EP83401638A EP0101380A3 (fr) 1982-08-13 1983-08-10 Nicotinamide 1-oxyde N-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant
CS835876A CS241064B2 (en) 1982-08-13 1983-08-10 Method of n-substituted nicotinamide's 1-oxide and its salts production
HU832829A HU191869B (en) 1982-08-13 1983-08-11 Process for producing new nicotinamide-1-oxide derivatives of histamine h-2 receptor-blocking activity and pharmaceutical compositions containing them
GR72198A GR78927B (fr) 1982-08-13 1983-08-11
DD83253927A DD213921A5 (de) 1982-08-13 1983-08-12 Verfahren zur herstellung von substituierten nicotinamid 1-oxyd n- und seinen salzen
CA000434507A CA1209995A (fr) 1982-08-13 1983-08-12 Procede pour la preparation de composes de nicotinamide 1-oxyde n-substitue et de ses sels, et les composes et sels ainsi obtenus
NO832894A NO832894L (no) 1982-08-13 1983-08-12 Fremgangsmaate for fremstilling av n-substituerte nikotinamid-1-oksyd-derivater
SU833634875A SU1212323A3 (ru) 1982-08-13 1983-08-12 Способ получени @ -замещенных 1-оксиникотинамида или их фармацевтически приемлемых солей
NZ205239A NZ205239A (en) 1982-08-13 1983-08-12 Nicotinamide 1-oxide derivatives and pharmaceutical compositions
FI832919A FI832919A (fi) 1982-08-13 1983-08-12 Foerfarande foer framstaellning av n-substituerad nikotinamid-1-oxid och dess salter
PT77192A PT77192B (fr) 1982-08-13 1983-08-12 Procede de preparation de nicotinamide 1-oxyde n-substitue et de ses sels
US06/522,749 US4514408A (en) 1982-08-13 1983-08-12 N-substituted nicotinamide 1-oxide as histamine H2 receptor blockers
MA20093A MA19871A1 (fr) 1982-08-13 1983-08-12 Procede de preparation de nicotinamide 1-oxyde n substitue et de ses sels .
YU01690/83A YU169083A (en) 1982-08-13 1983-08-12 Process for making n-substituted nicotinamide-1-oxides and their salts
DK367683A DK367683A (da) 1982-08-13 1983-08-12 Fremgangsmaade til fremstilling af n-substituerede 1-oxido-nicotinamider og salte deraf
PL1983243410A PL141540B1 (en) 1982-08-13 1983-08-12 Process for preparing n-substituted 1-oxide of nicotinic acid amide
OA58088A OA07521A (fr) 1982-08-13 1983-08-12 Nicotonamide 1-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8306681A FR2544717B1 (fr) 1983-04-22 1983-04-22 Nicotinamide l-oxyde n-substitue, ses sels, procede pour leur preparation et compositions pharmaceutiques en contenant

Publications (2)

Publication Number Publication Date
FR2544717A1 FR2544717A1 (fr) 1984-10-26
FR2544717B1 true FR2544717B1 (fr) 1986-03-28

Family

ID=9288140

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8306681A Expired FR2544717B1 (fr) 1982-08-13 1983-04-22 Nicotinamide l-oxyde n-substitue, ses sels, procede pour leur preparation et compositions pharmaceutiques en contenant

Country Status (1)

Country Link
FR (1) FR2544717B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS568352A (en) * 1979-07-03 1981-01-28 Shionogi & Co Ltd Aminoalkylvenzene derivative
US4293557A (en) * 1979-07-03 1981-10-06 Teikoku Hormone Mfg. Co., Ltd. Antiulcer phenoxypropylamine derivatives

Also Published As

Publication number Publication date
FR2544717A1 (fr) 1984-10-26

Similar Documents

Publication Publication Date Title
BE896986A (fr) Derives d'indole, procedes pour leur preparation et composition pharmaceutiques les contenant
PT77488A (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
FR2542740B1 (fr) Derives de thiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
MC1390A1 (fr) Derives de pyrazolopyridazine,procede pour leur preparation et compositions pharmaceutiques les contenant
BE881245A (fr) N-benzylimidazoles inhibiteurs selectifs de thromboxanne-synthetase, leur procede de production et compositions pharmaceutiques les contenant
MC2098A1 (fr) Sels de glycosaminoglycanes,procedes pour leur preparation et compositions pharmaceutiques les contenant
BE849810A (fr) Nouvelles pyrimidones, procede pour les preparation et compositions pharmaceutiques les contenant
LU81132A1 (fr) 2-(2-thenoylthio)-propionylglycine,procede pour sa preparation et compositions pharmaceutiques la contenant
BE885385A (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant
FR2537584B1 (fr) Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
FR2599034B1 (fr) Derives de 1-(hydroxystyryl)-5h-2,3,-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant
BE885156A (fr) Psoralenes, leur procede de preparation et compositions pharmaceutiques les contenant
FR2628419B1 (fr) Nouveaux sels antiviraux, compositions pharmaceutiques les contenant et procede pour les preparer
FR2588868B1 (fr) Acyl-7 benzoxazinones et leurs derives, procede pour les obtenir et compositions pharmaceutiques les contenant
PT74651B (fr) Procede de preparation de derives de pyridine et de compositions pharmaceutiques les contenant
FR2539126B1 (fr) Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant
OA07521A (fr) Nicotonamide 1-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2547821B1 (fr) Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant
BE885633A (fr) Derives de 1,2,4-oxadiazolin-5-one, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2586686B1 (fr) Nouvelles substances antibiotiques et antitumorales, procede pour leur obtention et isolation; compositions pharmaceutiques les contenant
FR2551440B1 (fr) Aminocyclopentanes, leur procede de preparation et compositions pharmaceutiques les contenant
FR2544717B1 (fr) Nicotinamide l-oxyde n-substitue, ses sels, procede pour leur preparation et compositions pharmaceutiques en contenant
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
ZA835728B (en) N-substituted nicotinamide 1-oxide,its salts,process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
ST Notification of lapse